The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer Receiving Platinum Based Chemotherapy

BACKGROUND: Adjuvant chemotherapy is a required treatment for most patients with epithelial ovarian cancer (EOC) or peritoneal cancer. However, it has many adverse events which may affect oncologic outcomes. Active hexose correlated compound (AHCC) has been reported to be an immunoenhancer to decrea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Asian Pac J Cancer Prev
Main Authors: Suknikhom, Wineeya, Lertkhachonsuk, Ruangsak, Manchana, Tarinee
Formato: Artigo
Idioma:Inglês
Publicado em: West Asia Organization for Cancer Prevention 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464477/
https://ncbi.nlm.nih.gov/pubmed/28440968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.3.633
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados